SCHEDULE 13G/A: Emergence Capital Entities Disclose 4.1% Beneficial Stake in Doximity, Inc. via Amended Schedule 13G Filing
Beneficial Ownership Report
Emergence Capital Partners and related entities have filed an Amendment No. 4 to their Schedule 13G, disclosing their collective beneficial ownership of 4.1% of Doximity, Inc.'s Class A Common Stock as of December 31, 2024.
Summary
- Emergence Capital Partners II, L.P. (ECP II) directly owns 4,820,546 shares of Class B Common Stock of Doximity, Inc., representing approximately 3.6% of the outstanding Class A Common Stock on an as-converted basis.
- Emergence Capital Opportunity I, L.P. (ECO I) directly owns 581,250 shares of Class A Common Stock, representing approximately 0.5% of the outstanding Class A Common Stock.
- Emergence Equity Partners II, L.P. (EEP II), as the sole general partner of ECP II, is deemed to beneficially own 4,820,546 shares of Class B Common Stock, also representing 3.6% of Class A Common Stock on an as-converted basis.
- Emergence Equity Partners VI, L.P. (EEP VI), as the sole general partner of ECO I, is deemed to beneficially own 581,250 shares of Class A Common Stock, representing 0.5% of Class A Common Stock.
- Emergence GP Partners, LLC (EGP), as the sole general partner of both EEP II and EEP VI, is deemed to beneficially own a total of 5,401,796 shares (4,820,546 Class B and 581,250 Class A), representing approximately 4.1% of the outstanding Class A Common Stock on an as-converted basis.
- Each share of Class B Common Stock is entitled to ten votes and automatically converts into one share of Class A Common Stock upon certain events.
- The percentage of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in Doximity's Form 10-Q filed on November 7, 2024.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain subjective language or information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an institutional investor in a publicly traded company within the healthcare technology sector. It reflects an ongoing investment position rather than a new strategic move or industry trend.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can be a factor in assessing investor confidence and potential influence on corporate governance, particularly given the dual-class share structure.
Key Dates
| Date | Description |
|---|---|
| 2024-10-31 | Date as of which 128,135,991 shares of Class A Common Stock were outstanding, used for percentage calculations. |
| 2024-12-31 | Date of event which requires filing of this statement. |
| 2025-02-13 | Date of filing of the Schedule 13G Amendment No. 4. |
Keywords
Doximity Inc., DXCM, Emergence Capital, Schedule 13G, Beneficial Ownership, Class A Common Stock, Class B Common Stock, SEC Filing, Investment, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.